Cargando…

The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security

Two new zoonotic coronaviruses causing disease in humans (Zumla et al. 2015a; Hui and Zumla 2015; Peiris et al. 2003; Yu et al. 2014) have been the focus of international attention for the past 14 years due to their epidemic potential; (1) The Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Azhar, Esam I., Lanini, Simone, Ippolito, Giuseppe, Zumla, Alimuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119928/
https://www.ncbi.nlm.nih.gov/pubmed/27966107
http://dx.doi.org/10.1007/5584_2016_133
_version_ 1783514864017211392
author Azhar, Esam I.
Lanini, Simone
Ippolito, Giuseppe
Zumla, Alimuddin
author_facet Azhar, Esam I.
Lanini, Simone
Ippolito, Giuseppe
Zumla, Alimuddin
author_sort Azhar, Esam I.
collection PubMed
description Two new zoonotic coronaviruses causing disease in humans (Zumla et al. 2015a; Hui and Zumla 2015; Peiris et al. 2003; Yu et al. 2014) have been the focus of international attention for the past 14 years due to their epidemic potential; (1) The Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) (Peiris et al. 2003) first discovered in China in 2001 caused a major global epidemic of the Severe Acute Respiratory Syndrome (SARS). (2) The Middle East respiratory syndrome coronavirus (MERS-CoV) is a new corona virus isolated for the first time in a patients who died of severe lower respiratory tract infection in Jeddah (Saudi Arabia) in June 2012 (Zaki et al. 2012). The disease has been named Middle East Respiratory Syndrome (MERS) and it has remained on the radar of global public health authorities because of recurrent nosocomial and community outbreaks, and its association with severe disease and high mortality rates (Assiri et al. 2013a; Al-Abdallat et al. 2014; Memish et al. 2013a; Oboho et al. 2015; The WHO MERS-CoV Research Group 2013; Cotten et al. 2013a; Assiri et al. 2013b; Memish et al. 2013b; Azhar et al. 2014; Kim et al. 2015; Wang et al. 2015; Hui et al. 2015a). Cases of MERS have been reported from all continents and have been linked with travel to the Middle East (Hui et al. 2015a; WHO 2015c). The World Health Organization (WHO) have held nine meetings of the Emergency Committee (EC) convened by the Director-General under the International Health Regulations (IHR 2005) regarding MERS-CoV (WHO 2015c). There is wishful anticipation in the political and scientific communities that MERS-CoV like SARS-CoV will disappear with time. However it’s been nearly 4 years since the first discovery of MERS-CoV, and MERS cases continue to be reported throughout the year from the Middle East (WHO 2015c). There is a large MERS-CoV camel reservoir, and there is no specific treatment or vaccine (Zumla et al. 2015a). With 10 million people visiting Saudi Arabia every year for Umrah and/or Hajj, the potential risk of global spread is ever present (Memish et al. 2014a; McCloskey et al. 2014; Al-Tawfiq et al. 2014a).
format Online
Article
Text
id pubmed-7119928
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-71199282020-04-06 The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security Azhar, Esam I. Lanini, Simone Ippolito, Giuseppe Zumla, Alimuddin Emerging and Re-emerging Viral Infections Article Two new zoonotic coronaviruses causing disease in humans (Zumla et al. 2015a; Hui and Zumla 2015; Peiris et al. 2003; Yu et al. 2014) have been the focus of international attention for the past 14 years due to their epidemic potential; (1) The Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) (Peiris et al. 2003) first discovered in China in 2001 caused a major global epidemic of the Severe Acute Respiratory Syndrome (SARS). (2) The Middle East respiratory syndrome coronavirus (MERS-CoV) is a new corona virus isolated for the first time in a patients who died of severe lower respiratory tract infection in Jeddah (Saudi Arabia) in June 2012 (Zaki et al. 2012). The disease has been named Middle East Respiratory Syndrome (MERS) and it has remained on the radar of global public health authorities because of recurrent nosocomial and community outbreaks, and its association with severe disease and high mortality rates (Assiri et al. 2013a; Al-Abdallat et al. 2014; Memish et al. 2013a; Oboho et al. 2015; The WHO MERS-CoV Research Group 2013; Cotten et al. 2013a; Assiri et al. 2013b; Memish et al. 2013b; Azhar et al. 2014; Kim et al. 2015; Wang et al. 2015; Hui et al. 2015a). Cases of MERS have been reported from all continents and have been linked with travel to the Middle East (Hui et al. 2015a; WHO 2015c). The World Health Organization (WHO) have held nine meetings of the Emergency Committee (EC) convened by the Director-General under the International Health Regulations (IHR 2005) regarding MERS-CoV (WHO 2015c). There is wishful anticipation in the political and scientific communities that MERS-CoV like SARS-CoV will disappear with time. However it’s been nearly 4 years since the first discovery of MERS-CoV, and MERS cases continue to be reported throughout the year from the Middle East (WHO 2015c). There is a large MERS-CoV camel reservoir, and there is no specific treatment or vaccine (Zumla et al. 2015a). With 10 million people visiting Saudi Arabia every year for Umrah and/or Hajj, the potential risk of global spread is ever present (Memish et al. 2014a; McCloskey et al. 2014; Al-Tawfiq et al. 2014a). 2016-12-14 /pmc/articles/PMC7119928/ /pubmed/27966107 http://dx.doi.org/10.1007/5584_2016_133 Text en © Springer International Publishing Switzerland 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Azhar, Esam I.
Lanini, Simone
Ippolito, Giuseppe
Zumla, Alimuddin
The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title_full The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title_fullStr The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title_full_unstemmed The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title_short The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
title_sort middle east respiratory syndrome coronavirus – a continuing risk to global health security
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119928/
https://www.ncbi.nlm.nih.gov/pubmed/27966107
http://dx.doi.org/10.1007/5584_2016_133
work_keys_str_mv AT azharesami themiddleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT laninisimone themiddleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT ippolitogiuseppe themiddleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT zumlaalimuddin themiddleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT azharesami middleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT laninisimone middleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT ippolitogiuseppe middleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity
AT zumlaalimuddin middleeastrespiratorysyndromecoronavirusacontinuingrisktoglobalhealthsecurity